semaglutide banned GLP-1 weight-loss drugs are a hot health topic. Now, critics are debating whether the medications should be in sports for potentially being performance-enhancing drugs. https://fox5sandiego.com/news/critics-concerned-glp-1-drugs-may-give Dose:30mg (10 Vials) reduction FDA Approved: Orforglipron (Foundayo)

semaglutide banned GLP-1 weight-loss drugs are a hot health topic. Now, critics are debating whether the medications should be in sports for potentially being performance-enhancing drugs. https://fox5sandiego.com/news/critics-concerned-glp-1-drugs-may-give Dose:30mg (10 Vials) reduction FDA Approved: Orforglipron (Foundayo)

FDA Approved: Orforglipron (Foundayo) — Oral GLP-1 Drug • FDA approved for chronic weight management • Indicated for obesity and overweight with comorbidities • Oral, once-daily GLP-1 receptor agonist • First non-peptide

Specific to GLP-1, berberine increases intestinal GLP-1 secretion through multiple pathways

reduction

Dose:30mg (10 Vials)

By expanding self-pay access to employees and their families, we ensure that more people receive safe, personalized care—guided by genetics, the microbiome, and glucose data—to improve outcomes and reduce avoidable discontinuation.” — Ranjan Sinha, Founder and CEO, Digbi Health